Short answer: these are not competitors. ChartMogul is operator-side subscription analytics with flexible data import. ChurnLens is buyer-side due diligence for a company you do not own yet. Most people arriving at this comparison need one clearly more than the other.
Nearly every tool in this category is operator-side: you connect your own billing account and watch your own revenue. ChurnLens is buyer-side: you send an export from a company you are considering buying, and it tells you whether the story that export tells is the same story the seller told you. That single difference — whose business is being measured, and who chose the definitions — decides which tool you want far more than any feature list.
ChartMogul launched in 2014 as a subscription-analytics platform, and is best known for its depth in cohort retention analysis and subscriber-level segmentation.
How it gets data: Billing integrations or direct CSV/API import — so a buyer genuinely can load a target's data. Commercially: Free below an entry MRR threshold, then priced on tracked MRR.
ChartMogul is the closest of the analytics platforms to being usable in diligence, because it will ingest a CSV. The gap is not data access — it is opinion. ChartMogul is a neutral platform: you map the columns, choose the definitions, build the segments and draw the conclusions. It will faithfully show you whatever you configured. It will not tell you that a 34% top-five concentration is a financing problem, and it does not emit a buyer-side grade you can put in a committee paper.
| Dimension | ChartMogul | ChurnLens |
|---|---|---|
| Primary user | Founders and operators running their own SaaS | Acquirers, PE and M&A analysts, and searchers buying one |
| Core job | Operator-side subscription analytics with flexible data import | One-off buyer-side acquisition risk report |
| Data it needs | Billing integrations or direct CSV/API import — so a buyer genuinely can load a target's data. | The target's raw subscription CSV export — no seller credentials |
| Whose definitions apply | The connected account's own configuration | Recomputed from raw rows, specifically to test the reported figure |
| Output | Dashboards, reports and trend charts | Benchmarked A–F revenue-quality grade plus a ranked red-flag report |
| Time to first answer | Continuous, once setup and integration are done | Minutes, from a single CSV upload |
| Commercial shape | Free below an entry MRR threshold, then priced on tracked MRR. | Free tier; one-off analysis from $9; paid tiers to $1,999 |
| Best for | Running a SaaS | Buying one |
This is the most genuine overlap of any tool on this list. If you are experienced, patient, and know exactly which cuts of the data expose an inflated retention story, ChartMogul can get you most of the way there. The difference is how much of the reasoning you supply yourself: ChartMogul is a very good instrument, and ChurnLens is an opinionated checklist that happens to run on the same raw data.
Load a target's export into ChartMogul and you will get an accurate cohort chart. Whether you notice that the cohorts thin out sharply at month 13 — the signature of annual plans not renewing — depends entirely on whether you thought to look at month 13. An acquisition-shaped tool asks that question by default; a general analytics platform waits for you to ask it.
Illustrative scenario, not a measured result from a named company.
Stay with ChartMogul if you want the deepest cohort analysis available and are happy to supply the diligence judgement yourself. Use ChurnLens if you want the acquisition-specific questions asked for you, and a defensible grade at the end. Plenty of people end up using both, at different moments: one before a deal closes, the other after.
A comparison page that only lists strengths is not much use in diligence, so here is the other side.
If any of those four are what you came for, ChartMogul or a tool like it is the better purchase, and we would rather say so here than after you have signed up.
ChartMogul is a subscription-analytics platform for teams running a SaaS business. ChurnLens reconstructs a target's churn from the outside, for the buyer.re is how they differ on data, output and price.
Short answer: ChartMogul is operator-side subscription analytics with flexible data import, and it is good at that. It is not a diligence tool. If you are testing whether a target's reported churn survives its own raw data, that is a different job — and the one ChurnLens was built for.
Nearly every tool in this category is operator-side: you connect your own billing account and watch your own revenue. ChurnLens is buyer-side: you send an export from a company you are considering buying, and it tells you whether the story that export tells is the same story the seller told you. That single difference — whose business is being measured, and who chose the definitions — decides which tool you want far more than any feature list.
ChartMogul launched in 2014 as a subscription-analytics platform, and is best known for its depth in cohort retention analysis and subscriber-level segmentation.
How it gets data: Billing integrations or direct CSV/API import — so a buyer genuinely can load a target's data. Commercially: Free below an entry MRR threshold, then priced on tracked MRR.
ChartMogul is the closest of the analytics platforms to being usable in diligence, because it will ingest a CSV. The gap is not data access — it is opinion. ChartMogul is a neutral platform: you map the columns, choose the definitions, build the segments and draw the conclusions. It will faithfully show you whatever you configured. It will not tell you that a 34% top-five concentration is a financing problem, and it does not emit a buyer-side grade you can put in a committee paper.
| Dimension | ChartMogul | ChurnLens |
|---|---|---|
| Primary user | Founders and operators running their own SaaS | Acquirers, PE and M&A analysts, and searchers buying one |
| Core job | Operator-side subscription analytics with flexible data import | One-off buyer-side acquisition risk report |
| Data it needs | Billing integrations or direct CSV/API import — so a buyer genuinely can load a target's data. | The target's raw subscription CSV export — no seller credentials |
| Whose definitions apply | The connected account's own configuration | Recomputed from raw rows, specifically to test the reported figure |
| Output | Dashboards, reports and trend charts | Benchmarked A–F revenue-quality grade plus a ranked red-flag report |
| Time to first answer | Continuous, once setup and integration are done | Minutes, from a single CSV upload |
| Commercial shape | Free below an entry MRR threshold, then priced on tracked MRR. | Free tier; one-off analysis from $9; paid tiers to $1,999 |
| Best for | Running a SaaS | Buying one |
This is the most genuine overlap of any tool on this list. If you are experienced, patient, and know exactly which cuts of the data expose an inflated retention story, ChartMogul can get you most of the way there. The difference is how much of the reasoning you supply yourself: ChartMogul is a very good instrument, and ChurnLens is an opinionated checklist that happens to run on the same raw data.
Load a target's export into ChartMogul and you will get an accurate cohort chart. Whether you notice that the cohorts thin out sharply at month 13 — the signature of annual plans not renewing — depends entirely on whether you thought to look at month 13. An acquisition-shaped tool asks that question by default; a general analytics platform waits for you to ask it.
Illustrative scenario, not a measured result from a named company.
Stay with ChartMogul if you want the deepest cohort analysis available and are happy to supply the diligence judgement yourself. Use ChurnLens if you want the acquisition-specific questions asked for you, and a defensible grade at the end. Plenty of people end up using both, at different moments: one before a deal closes, the other after.
A comparison page that only lists strengths is not much use in diligence, so here is the other side.
If any of those four are what you came for, ChartMogul or a tool like it is the better purchase, and we would rather say so here than after you have signed up.
They do different jobs, so it depends on which side of a transaction you are on. ChartMogul is operator-side subscription analytics with flexible data import; ChurnLens is buyer-side due diligence. Keep ChartMogul if you want the deepest cohort analysis available and are happy to supply the diligence judgement yourself. Use ChurnLens if you want the acquisition-specific questions asked for you, and a defensible grade at the end.
Partly, and more than most. ChartMogul can ingest a target's CSV, so data access is not the blocker. What it will not do is decide which cuts of that data matter for an acquisition, or hand you a buyer-side grade — you supply the diligence judgement yourself.
No, and that is deliberate. ChurnLens works from the raw subscription CSV a seller exports, so you can run diligence on a target without ever holding their live billing credentials — which is the situation buyers are actually in.
A benchmarked A–F revenue-quality grade and a ranked red-flag report tuned to acquisition risk: hidden churn, customer-concentration risk, annual-plan decay and zombie MRR — all recomputed from the raw rows rather than reported according to the seller's own configuration.
ChartMogul tracks subscription metrics. We tell acquirers whether your SaaS is worth buying.
ChartMogul starts at $100/mo for subscription analytics. ChurnLens is built for M&A due diligence — not just churn tracking, but buyer-ready revenue quality reports. Single-company analysis is free.
Send the subscription CSV a seller gave you and get a revenue-quality grade plus a ranked red-flag report.
Try ChurnLens free →They do different jobs, so it depends on which side of a transaction you are on. ChartMogul is operator-side subscription analytics with flexible data import; ChurnLens is buyer-side due diligence. Keep ChartMogul if you want the deepest cohort analysis available and are happy to supply the diligence judgement yourself. Use ChurnLens if you want the acquisition-specific questions asked for you, and a defensible grade at the end.